KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 14,471 Value ($000) $597 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 32,529 Value ($000) $1,263 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 31,739 Value ($000) $878 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 121,859 Value ($000) $2,706 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 122,051 Value ($000) $2,414 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 91,669 Value ($000) $2,291 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 115,143 Value ($000) $2,150 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	14,471	$597	$40.11	$35.20 - $44.42
Q3 2025	32,529	$1,263	$32.49	$26.27 - $39.00
Q2 2025	31,739	$878	$25.46	$18.25 - $30.69
Q1 2025	121,859	$2,706	$20.58	$17.82 - $24.31
Q4 2024	122,051	$2,414	$22.82	$19.47 - $28.15
Q3 2024	91,669	$2,291	$24.36	$17.38 - $27.92
Q2 2024	115,143	$2,150	$18.73	$16.56 - $20.52